These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3559725)

  • 1. Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice.
    Olson JJ; Beck DW; Schlechte JA; Loh PM
    J Neurosurg; 1987 Apr; 66(4):584-7. PubMed ID: 3559725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo.
    Matsuda Y; Kawamoto K; Kiya K; Kurisu K; Sugiyama K; Uozumi T
    J Neurosurg; 1994 Mar; 80(3):527-34. PubMed ID: 8113866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal manipulation of meningiomas in vitro.
    Olson JJ; Beck DW; Schlechte J; Loh PM
    J Neurosurg; 1986 Jul; 65(1):99-107. PubMed ID: 3712034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mifepristone (RU 486) treatment of meningiomas.
    Lamberts SW; Tanghe HL; Avezaat CJ; Braakman R; Wijngaarde R; Koper JW; de Jong H
    J Neurol Neurosurg Psychiatry; 1992 Jun; 55(6):486-90. PubMed ID: 1619417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium channel antagonists augment hydroxyurea- and ru486-induced inhibition of meningioma growth in vivo and in vitro.
    Ragel BT; Gillespie DL; Kushnir V; Polevaya N; Kelly D; Jensen RL
    Neurosurgery; 2006 Nov; 59(5):1109-20; discussion 1120-1. PubMed ID: 17143245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone.
    Grunberg SM; Weiss MH; Spitz IM; Ahmadi J; Sadun A; Russell CA; Lucci L; Stevenson LL
    J Neurosurg; 1991 Jun; 74(6):861-6. PubMed ID: 2033444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of multiple intracranial meningiomas with the antiprogesterone receptor agent mifepristone (RU486).
    Touat M; Lombardi G; Farina P; Kalamarides M; Sanson M
    Acta Neurochir (Wien); 2014 Oct; 156(10):1831-5. PubMed ID: 25078073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of antiprogestational therapy for meningiomas.
    Grunberg SM
    Hum Reprod; 1994 Jun; 9 Suppl 1():202-7. PubMed ID: 7962466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway.
    Schrell UM; Rittig MG; Anders M; Kiesewetter F; Marschalek R; Koch UH; Fahlbusch R
    J Neurosurg; 1997 May; 86(5):845-52. PubMed ID: 9126901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mifepristone: antineoplastic studies.
    Sartor O; Figg WD
    Clin Obstet Gynecol; 1996 Jun; 39(2):498-505. PubMed ID: 8734014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma.
    Grunberg SM; Weiss MH; Russell CA; Spitz IM; Ahmadi J; Sadun A; Sitruk-Ware R
    Cancer Invest; 2006 Dec; 24(8):727-33. PubMed ID: 17162554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of systemic celecoxib on human meningioma after intracranial transplantation into nude mice.
    Friedrich S; Schwabe K; Grote M; Krauss JK; Nakamura M
    Acta Neurochir (Wien); 2013 Jan; 155(1):173-82. PubMed ID: 23143216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
    Bakker GH; Setyono-Han B; Henkelman MS; de Jong FH; Lamberts SW; van der Schoot P; Klijn JG
    Cancer Treat Rep; 1987 Nov; 71(11):1021-7. PubMed ID: 3119199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of meningioma cell growth by sex steroid hormones in vitro.
    Jay JR; MacLaughlin DT; Riley KR; Martuza RL
    J Neurosurg; 1985 May; 62(5):757-62. PubMed ID: 3989596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor.
    Baulieu EE
    Science; 1989 Sep; 245(4924):1351-7. PubMed ID: 2781282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningioma and hormonal influences.
    Wahab M; Al-Azzawi F
    Climacteric; 2003 Dec; 6(4):285-92. PubMed ID: 15006250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracranial injection of human meningioma cells in athymic mice: an orthotopic model for meningioma growth.
    McCutcheon IE; Friend KE; Gerdes TM; Zhang BM; Wildrick DM; Fuller GN
    J Neurosurg; 2000 Feb; 92(2):306-14. PubMed ID: 10659019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
    Schaison G; George M; Lestrat N; Reinberg A; Baulieu EE
    J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone dependency of meningiomas.
    Lancet; 1989 Jun; 1(8651):1381-2. PubMed ID: 2567386
    [No Abstract]   [Full Text] [Related]  

  • 20. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
    Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
    J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.